微血管周细胞收缩功能的研究进展.pdfVIP

·1630 · 医学 综述 20 12 年 6 月第 18 卷第 11 期 Medical Recapitulate, Jun. 2012, Vol. 18, No. 11 USA, 2007, 104 ( 52) : 20932-20937. therapy in primary human glioblastoma cells through continued ac- [ 24] Benedettini E, Sholl LM, Peyton M, et al. Met activati on in non- tivation of phosphoinositide 3-kinase signaling [ J] . Cancer Res, small cell lung cancer is associated with de novo resistance to egfr 2002 , 62( 1) : 200-207. inhibitors and the development of brain metastasis [ J] . Am J [ 32] Oxnard GR, Arcila ME, Chmielecki J, et al. New strategies in over- Pathol , 20 10, 177( 1) : 4 15-423. coming acquired resistance to epidermal growth factor receptor tyro- [ 25] Bianco R, Damiano V, Gelardi T, et al. Rational combination of tar- sine kinase inhibitors in lung cancer [ J] . Clin Cancer Res, 20 11, geted therapies as a strategy to overcome the mechanisms of resist- 17 ( 17) : 5530-5537. ance to inhibitors of EGFR signaling [ J] . Curr Pharm Des, 2007 , [ 33] Ravindtanath N, Wion D, Brachet P, et al. Epi dermal growth factor 13( 33) : 3358 -3367 . modulats the expression of vascular endothelial growth factor in the [ 26] Janmaat ML, Kruyt FA, Rodriguez JA , et al. Response to epidermal human prostate [ J] . J Androl, 200 1, 22( 3) : 432-443. growth factor receptor inhibitors in nonsmall cell lung cancer cells: [ 34] Goldman CK, Kim J, Wong WL, et al. Epidermal growth factor limited antiproliferative effects and absence of apoptosis associated stimulates vascular endothelial growth factor production by